Results 21 to 30 of about 4,595,974 (209)

Anticoagulation for Left Ventricle Thrombus—Case Series and Literature Review for Use of Direct Oral Anticoagulants

Journal of Cardiovascular Development and Disease, 2023
Left ventricular thrombus is a known complication following acute myocardial infarction that can lead to systemic thromboembolism. To obviate the risk of thromboembolism, the patient needs anticoagulation in addition to dual antiplatelet therapy. However,
Akshyaya Pradhan, Monika Bhandari, Pravesh Vishwakarma, Chiara Salimei, Ferdinando Iellamo, Rishi Sethi, Marco Alfonso Perrone   +6 more
doaj   +1 more source

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol

Systematic Reviews, 2019
Background and purpose Cerebral venous thrombosis causes disability from venous infarct and hemorrhage and potential mortality. Anticoagulation improves survival and disability outcomes, yet direct oral anticoagulants are currently not indicated in ...
Gauruv Bose, Justin Graveline, Vignan Yogendrakumar, Dean Fergusson, Dar Dowlatshahi   +4 more
doaj   +1 more source

Direct-acting oral anticoagulants: An overview

Saudi Journal of Medicine and Medical Sciences, 2017
In today's practice, an increasing number of patients are prescribed anticoagulant therapy. Short-term anticoagulation as a primary or secondary prophylaxis of thrombosis is standard of care in many clinical indications.
Hatem H Salem
doaj   +1 more source

Safety and differences between direct oral anticoagulants and vitamin K antagonists in the risk of post-traumatic intrathoracic bleeding after rib fractures in elderly patients

Emergency Care Journal, 2021
Closed chest traumas are frequent consequences of falls in the elderly. The presence of concomitant oral anticoagulant therapy can increase the risk of post-traumatic bleeding even in cases of trauma with non-severe dynamics. There is limited information
Gianni Turcato, Arian Zaboli, Andrea Tenci, Giorgio Ricci, Massimo Zannoni, Christoph Scheurer, Anton Wieser, Antonio Maccagnani, Antonio Bonora, Norbert Pfeifer   +9 more
doaj   +1 more source

Global access to affordable direct oral anticoagulants [PDF]

, 2021
Poor control of cardiovascular disease accounts for a substantial proportion of the disease burden in developing countries, but often essential anticoagulant medicines for preventing strokes and embolisms are not widely available.
Magrini, Nicola, Schünemann, Holger J, Neumann I., Moja L., Schunemann, Holger, Neumann, Ignacio, Cooke, Graham, Bero L., Cooke G., Magrini N., Moja, Lorenzo, Bero, Lisa, Schunemann H. J., Nicola Magrini, Ignacio Neumann, Lorenzo Moja, Graham Cooke, Holger Schünemann, Lisa Bero   +18 more
core   +1 more source

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)

Biomedicines, 2021
The introduction of direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban, apixaban, edoxaban, and betrixaban, provides safe and effective alternative to previous anticoagulant therapies.
Claire Dunois
doaj   +1 more source

The new, direct, target-specific oral anticoagulants

Journal of Applied Hematology, 2015
In recent years, numerous alternatives to VKAs have been developed, the first competitors to warfarin are the novel oral anticoagulants (NOAC) or better referred to as Direct Oral Anti-Coagulant (DOAC) or Target Specific Oral Anti-coagulant (TSOAC ...
Nevine A Kassim
doaj   +1 more source

Systematic errors in the choice of dose level of direct oral anticoagulants: urgency of an issue and approaches to its solution

Медицинский совет, 2021
The article presents updated information on the frequency of use of non-recommended low dosing of direct oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban).
S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina   +3 more
doaj   +1 more source

Is Left Atrial Appendage Occlusion Always Better than Direct Oral Anticoagulants?

, 2021
Is Left Atrial Appendage Occlusion Always Better than Direct Oral ...
김준
core   +1 more source

Rivaroxaban Treatment for Heparin-Induced Thrombocytopenia: A Case Report and a Review of the Current Experience

Case Reports in Hematology, 2020
Heparin-induced thrombocytopenia is a life-threatening complication of exposure to heparin. Heparin-induced thrombocytopenia results from an autoantibody directed against platelet factor 4 in complex with heparin.
Mohamed Aon, Omar Al-Shammari
doaj   +1 more source